ColBar LifeScience
Acquired- Headquarters
- Herzliya
- Business Model
- B2B
About
ColBar LifeScience was an Israeli biomaterials company based in Herzliya specializing in collagen-based products for reconstructive medicine and tissue engineering, including the Evolence dermal filler for facial wrinkles and the Ossix-PLUS glycated collagen barrier membrane used in bone regeneration. The company was later acquired by Johnson & Johnson, whose Janssen-Ortho subsidiary distributed its collagen filler products.
Summary
ColBar LifeScience is a Biotech company based in Herzliya, Israel. Investors include Johnson & Johnson Innovation.
Sign up to view the funding chart
Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Jul 2006
Investors
Similar Companies
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biopharmaceutical services company
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Specialty pharmaceutical company
Global oncology biopharmaceutical company developing and commercializing cancer treatments, now r...